Qualcomm and Arm Trial Ends in Hung Jury Over Licensing Breach Allegations
Qualcomm's lawsuit against Arm Holdings ended in a hung jury, with deliberations set to resume. Qualcomm alleges Arm breached licensing agreements, while Arm denies any harm. The case impacts Qualcomm's chip business and licensing terms. Qualcomm's stock has risen 34% in six months, with a price target of $194. The company reported $9.9B revenue and $2.21 EPS in its latest quarter, with growth in automotive and data center sectors.
How this was made
The 30-second read
Why it matters
The immediate trading driver is uncertainty: no verdict yet, with the jury set to return Tuesday. Longer-term, the case could influence terms for newer Arm versions and therefore Qualcomm’s licensing economics and product roadmap risk.
Market read
Litigation remains unresolved, creating a near-term catalyst (Tuesday jury return) and a longer-term risk to Arm-related licensing terms that Qualcomm says underpin its chip business.
What to watch
The article notes a separate bench trial on good-faith negotiation that could arrive later, meaning the most market-moving legal signal may not be the hung jury itself.
Background
Qualcomm is suing Arm over alleged licensing agreement breaches, including withheld software patches/tools and a pricing constraint tied to Arm processor designs; the architecture license runs until 2033.
Ticker impact
Qualcomm’s Delaware jury trial against Arm ended in a hung jury, with Qualcomm alleging licensing breaches that could affect Arm terms through 2033.
Likely choppy trading around the next jury session as investors reprice litigation risk and any downstream impact on Qualcomm’s licensing economics.
The article centers on Qualcomm’s lawsuit outcome being unresolved, explicitly noting the jury will return Tuesday, while also tying Qualcomm’s chip business to Arm keeping its promises.
Market effects
Highlights ongoing IP licensing friction in the semiconductor ecosystem, which can raise perceived risk for Arm-dependent business models.
Primarily US-listed semiconductor sentiment, with litigation headlines potentially spilling into broader chip and mobile-software licensing risk appetite.
Arm licensing terms are globally relevant for chip design and royalty structures, so outcomes can influence cross-border supply-chain expectations.
Counterpoint
A hung jury may reduce immediate downside versus a clear loss, since Arm still has to face unresolved allegations and the dispute could settle on commercial terms.
Key entities
- companyQualcomm
US-listed chipmaker suing Arm over alleged licensing breaches; jury trial ended in a hung jury with a return date set.
- companyArm Holdings
Defendant in the licensing breach allegations; argues Qualcomm suffered no harm and seeks leverage in licensing-term negotiations.
- companyMeta
Referenced in Qualcomm’s claim that Arm leaked a 2024 letter to Bloomberg about Qualcomm’s alleged breach.
